Press Releases

12345678910
VettaFi Accelerates Into the New Space Age: Pioneering "Day-One" Index Inclusion for SpaceX and Industry Titans
New York, New York--(Newsfile Corp. - April 20, 2026) - VettaFi, a differentiated index provider with modern distribution solutions and...
Via Newsfile · April 20, 2026
Searchlight Resources Adds Mari Lake High Grade Gold Project to Its Saskatchewan Gold Portfolio
Historical Data Highlights22 drillholes, 39 trenches and several pits. Multiple reports of Visible Gold.Gold mineralized structure over 700 metres in...
Via Newsfile · April 20, 2026
PharmaTher's Microneedle Patch Platforms Positioned to Benefit from Major U.S. Catalysts in Psychedelics and Peptides
U.S. regulatory momentum in psychedelics and peptides could open new commercial opportunities for PharmaTher's PatchPrint™ automated manufacturing platform and PharmaPatch™...
Via Newsfile · April 20, 2026
ST GROUP : Prolongation de la période de souscription de son introduction en bourse sur Lise
Via Actus News · April 20, 2026
Burcon Achieves Record Production, Expands to More than 20 Buying Customers and Evaluates Additional Capacity Expansion
Vancouver, British Columbia--(Newsfile Corp. - April 20, 2026) - Burcon NutraScience Corporation (TSX: BU) (OTCQB: BRCNF) ("Burcon" or the "Company"),...
Via Newsfile · April 20, 2026
McKesson Signs Agreement with Apollo Funds for Strategic Minority Interest in Medical-Surgical Solutions
McKesson Corporation (NYSE: MCK), a leading Healthcare Services company, today announced it has entered into a definitive agreement with funds managed by affiliates of Apollo (“Apollo Funds”), under which Apollo Funds will acquire a minority ownership interest in McKesson’s Medical-Surgical Solutions (“MMS”) business. This transaction represents a meaningful milestone as McKesson executes its separation strategy of MMS in preparation of a planned initial public offering.
By McKesson Corporation · Via Business Wire · April 20, 2026
Maxell Establishes Corporate Byline “Micro batteries. Maximum impact.”
Maxell, Ltd. (TOKYO: 6810) has established the new corporate byline “Micro batteries. Maximum impact.” with the aim of evolving its corporate brand and strengthening its messaging in the global market.
By Maxell, Ltd. · Via Business Wire · April 20, 2026
Saildrone Unveils Spectre, a New Class of High-Speed Unmanned Surface Vessel for Naval Operations
Saildrone, the world leader and most experienced operator of unmanned surface vehicles (USVs), today released the design of the Saildrone Spectre, the culmination of two years of intense design work, leveraging over 10 years of operational USV experience.
By Saildrone · Via Business Wire · April 20, 2026
Leonardo DRS Launches New Maritime Counter-UAS Capability to Defeat Aerial Unmanned Threats at Sea
Leonardo DRS, Inc. (Nasdaq: DRS) announced today it has successfully integrated its Maritime Mission Equipment Package (M-MEP) on an autonomous unmanned surface vessel (AUSV), delivering a new counter-unmanned aerial system (C-UAS) capability designed to detect, track, identify, and defeat aerial unmanned threats operating in the maritime domain. Built for rapid integration on crewed and uncrewed platforms, the solution provides a mission-ready layer of protection for ships, ports, littoral infrastructure, and expeditionary forces facing an increasingly complex drone threat environment.
By Leonardo DRS, Inc. · Via Business Wire · April 20, 2026
NFTYDoor Becomes Independent Company and Expands Home Equity Credit Box
NFTYDoor, an end-to-end platform for unlocking the $21 trillion in tappable home equity, today announced that it is now operating as a fully independent company. This transition enables NFTYDoor to better serve its core partner channels through a significant expansion of the platform's credit box and partner economics.
By NFTYDoor · Via Business Wire · April 20, 2026
Treasure Data® Becomes Treasure AI™, Delivering 10x Value to Marketers in 10 Minutes with Its Agentic Experience Platform
Treasure AI, the agentic experience platform for brands to acquire, retain, and grow their most valuable customers 24/7, today announced a landmark evolution of its brand and platform. Treasure AI is built for brands who believe that AI, harnessed by human warmth and creativity, can drive smarter customer engagement, stronger retention, and measurable growth.
By Treasure AI · Via Business Wire · April 20, 2026
Hadron Energy Aligns Valuation for Business Combination to $600M, Signaling Long-Term Market Discipline After GigCapital7 Form S-4 Registration Statement Declared Effective
Hadron Energy, Inc. (“Hadron” or the “Company”), a developer of micro-modular reactor (MMR) technology, today announced two significant milestones on its path to becoming a publicly traded company to be listed on the Nasdaq Stock Market under the ticker symbol “HDRN.” First, Hadron and GigCapital7 have agreed to updated transaction terms reflecting a modified pro-forma equity valuation of Hadron of approximately $600 million to align with current public market conditions and the Company’s commitment to entering the public markets from a position of credibility and long-term strength. Second, the U.S. Securities and Exchange Commission (“SEC”) declared the Form S-4 registration statement of GigCapital7 Corp. (Nasdaq: GIG) (“GigCapital7”), for which the Company is a co-registrant, effective on April 15, 2026, enabling GigCapital7 to proceed with its special shareholders meeting to seek approval by its shareholders of the proposed business combination on May 7, 2026.
By Hadron Energy, Inc. · Via Business Wire · April 20, 2026
Motorola Solutions Redefines Crime Center Operations, Centering Workflows Around Measurable “Missions”
Motorola Solutions (NYSE: MSI) today announced a fundamental evolution of its CommandCentral Aware platform, establishing a new standard for real-time crime center operations. The platform now centers intelligence analysts’ activities around a new, measurable unit of work called a ‘mission’ - a unified digital workspace that enables them to seamlessly log, analyze and measure every investigative action in real time. The company’s mission-critical AI, Assist, operates continuously within the mission to support analysts in aggregating and highlighting the most vital data. As a replayable timeline, each mission shows exactly how an incident was managed and closed, helping agencies refine operations and solve more crimes, more quickly.
By Motorola Solutions · Via Business Wire · April 20, 2026
Vizient Showcases Integrated Supply Chain Capabilities at Spring IDN to Strengthen Trust in Healthcare Performance
Vizient® is showcasing an integrated set of supply chain capabilities at the Spring IDN Summit and Reverse Expo designed to help health systems strengthen trust across purchasing, analytics and strategic partnership. The event begins today in Orlando, Fla.
By Vizient, Inc. · Via Business Wire · April 20, 2026
LightSpun Names Healthcare Growth Veteran Bill Henderson as Strategic Advisor to the CEO, Accelerating National Expansion
LightSpun, the AI-powered dental insurance administration platform now supporting 175,000+ providers nationwide has named Bill Henderson as Strategic Advisor to the CEO. Henderson will lead national growth strategy and expand partnerships with Commercial, Medicaid and Medicare managed Healthcare organizations.
By LightSpun · Via Business Wire · April 20, 2026
Shane Miller, CFP®, CRPS®, CEPA®, Joins Prime Capital Financial
Prime Capital Financial announces the addition of Shane Miller, CFP®, CRPS®, CEPA®, as partner and managing director, to the firm’s Fort Worth, Texas, office. Miller brings more than a decade of experience in comprehensive financial planning and will support the firm’s continued growth in the Texas market while further enhancing its tax-focused planning capabilities.
By Prime Capital Financial · Via Business Wire · April 20, 2026
Diversified Appoints Tyler Affolter as Chief Revenue Officer to Support Next Phase of Growth
Diversified, a global leader in audiovisual, broadcast and digital experience integration, today announced the appointment of Tyler Affolter as chief revenue officer (CRO), a strategic leadership move that reflects the company’s continued focus on growth at the intersection of media, workplace and digital experience.
By Diversified · Via Business Wire · April 20, 2026
Source Support Services Unveils the Unified Services Platform
Source Support Services, a leading provider of global IT services for more than 25 years, today announced the launch of its Unified Services Platform, a next‑generation, human-centered, Salesforce‑native service delivery operating system designed to orchestrate the world of work at scale across the world’s most complex, mission‑critical infrastructure environments.
By Source Support Services · Via Business Wire · April 20, 2026
Integrated Data Services Achieves CMMC 2.0 Level 2 Certification, Reinforcing Commitment to Protecting Defense Data
Integrated Data Services, LLC (IDS), a leading provider of mission-critical financial technology solutions to the United States government, today announces that it has achieved Cybersecurity Maturity Model Certification (CMMC) 2.0 Level 2 certification following a successful third-party assessment by an authorized Certified Third-Party Assessment Organization (C3PAO).
By Integrated Data Services, LLC · Via Business Wire · April 20, 2026
o9 Selected by Chow Tai Fook Jewellery Group to Optimize Data-Driven Retail Planning
o9, a leading software company that is powering enterprise planning and decisioning models across 30-plus industry verticals with its groundbreaking, AI-powered Digital Brain platform, today announced its partnership with Chow Tai Fook Jewellery Group (Chow Tai Fook), a global Chinese luxury brand, to enhance its end-to-end retail planning capabilities.
By o9 Solutions · Via Business Wire · April 20, 2026
Nanox Announces Fourth Quarter of 2025 Financial Results and Provides Business Updates
Advanced commercialization in the US, signing multiple new customer and distribution agreements for Nanox.ARC and accelerated activities around Nanox.AI
By Nano-X Imaging Ltd · Via GlobeNewswire · April 20, 2026
Calidi Biotherapeutics Presents New Data on Its Differentiated Approach to In Situ T-Cell Engagers Including a New Candidate Targeting TROP-2 at the AACR Annual Meeting in April 2026
SAN DIEGO, April 20, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics, Inc. (NYSE American: CLDI) (“Calidi” or the “Company”), a biotechnology company pioneering the development of targeted genetic medicines, presented new data at the American Association of Cancer Research (AACR) annual meeting in San Diego, California on April 19, 2026. The Company demonstrated new data on its approach of simultaneously activating T-cells while inducing the expression of T-cell engagers specifically in situ in the tumor microenvironment (“TME”). The poster is available here.
By Calidi Biotherapeutics, Inc · Via GlobeNewswire · April 20, 2026
Fulcrum Therapeutics to Host First Quarter 2026 Financial Results Conference Call and Webcast on Monday, April 27, 2026, at 8:00 a.m. ET
CAMBRIDGE, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (the “Company”) (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on developing small molecules to improve the lives of patients with genetically defined rare diseases, today announced that its first quarter 2026 financial results will be released on Monday, April 27, 2026, before the U.S. financial markets open. Management will host a conference call and webcast at 8:00 a.m. ET to discuss the results and provide an update on recent corporate developments.
By Fulcrum Therapeutics, Inc. · Via GlobeNewswire · April 20, 2026
Cole West Closes on 38 Homesites in Northern Utah for New Community
Single-family homes in the Lone Tree community coming to Davis County
By Cole West · Via GlobeNewswire · April 20, 2026
Axe Compute Unveils Compute Reserve Dashboard, Giving Investors a Unified View of Its NASDAQ Stock and Operational Strategic Compute Reserve
Purpose-built for the neocloud era: a unified view of Axe Compute's NASDAQ equity and its Strategic Compute Reserve (SCR), the operational reserve that funds enterprise access to 435,000+ GPUs across 200+ global locations
By Axe Compute Inc · Via GlobeNewswire · April 20, 2026
Abacus Global Management to Participate in the 2026 Milken Institute Global Conference
ORLANDO, Fla., April 20, 2026 (GLOBE NEWSWIRE) -- Abacus Global Management, Inc. ("Abacus" or the "Company") (NYSE: ABX), a leader in the alternative asset management industry, today announced that it will participate in the 2026 Milken Institute Global Conference, taking place May 3–6, 2026 at The Beverly Hilton and Waldorf Astoria Beverly Hills in Beverly Hills, CA. The announcement marks the Company's first appearance at the annual gathering, which convenes thousands of leaders from across finance, business, government, health and philanthropy.
By Abacus Global Management · Via GlobeNewswire · April 20, 2026
2027 Kia Telluride Adds Hybrid Option Rated at Up to 35 MPG
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- (Feature Impact) Three-row SUVs continue to evolve as drivers look for vehicles that balance everyday practicality with comfort, technology and capability. Automakers are responding with models designed to support family life, long road trips and outdoor travel.
By Feature Impact · Via GlobeNewswire · April 20, 2026
The Double D Foundation Announces Major Gift From Patriot Mobile
Black Creek, GA, April 20, 2026 (GLOBE NEWSWIRE) -- Today, The Double D Foundation announced a significant financial commitment from Patriot Mobile, America’s only Christian conservative wireless provider. The announcement was made at the NRA Annual Meetings & Exhibits in Houston, Texas, underscoring the national significance of this investment and Patriot Mobile’s continued leadership in defending constitutional freedoms.
By Patriot Mobile · Via GlobeNewswire · April 20, 2026
Amneal Announces Additional Positive Interim Phase 4 ELEVATE-PD Results with CREXONT® for Parkinson’s Disease, Including Over 3 More Hours of Daily “Good On” Time When Switching from RYTARY®
BRIDGEWATER, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) (“Amneal” or the “Company”), today announced new positive interim results from its ongoing Phase 4 ELEVATE-PD study, presented at the 2026 American Academy of Neurology (AAN).
By Amneal Pharmaceuticals LLC · Via GlobeNewswire · April 20, 2026
ZJK Industrial Co., Ltd. Advances Localization Strategy in Vietnam to Strengthen Global Production Network
SHENZHEN, China, April 20, 2026 (GLOBE NEWSWIRE) -- ZJK Industrial Co., Ltd. (NASDAQ: ZJK) (“ZJK Industrial”, “ZJK” or the “Company”), a high-tech precision parts and hardware manufacturer serving artificial intelligence (AI) infrastructure, consumer electronics, electric vehicles, aerospace, and other smart technologies, today announced that it is advancing a localized operational model for its Vietnamese subsidiary as part of its ongoing global operations planning to support a more balanced and sustainable global production network.
By ZJK Industrial Co., Ltd. · Via GlobeNewswire · April 20, 2026
Toshiba Honors Earth Day 2026 Throughout the Year
Toshiba America Business Solutions celebrates Earth Day 2026 throughout the calendar. The company honors our planet year-round by facilitating the reforestation of trees in ecologically sensitive areas worldwide while also sparing open land from e-waste.
By Toshiba · Via Business Wire · April 20, 2026
Aptean introduces AI platform and AI agents for Business Central On-Premises Customers
Offering Partners a New Recurring-Revenue Opportunity — Exclusive Preview at Directions North America
By Aptean Inc. · Via GlobeNewswire · April 20, 2026
MainStreet Bancshares, Inc. Announces First Quarter 2026 Results
Net Interest Margin Expands on Disciplined Funding Strategy
By MainStreet Bancshares, Inc. · Via GlobeNewswire · April 20, 2026
Atsena Therapeutics Receives Data Monitoring Committee Recommendation to Proceed with Pivotal Part C Cohort of Phase 1/2/3 LIGHTHOUSE Trial Evaluating ATSN-201 in Patients with X-linked Retinoschisis
Patient screening to begin this month
By Atsena Therapeutics · Via GlobeNewswire · April 20, 2026
Helus Pharma Announces Chief Executive Officer Transition; Eric So to Resume Role as Interim Chief Executive Officer
This news release constitutes a “designated news release” for the purpose of the Company’s prospectus supplement dated December 30, 2025, to its short form base shelf prospectus dated September 17, 2025, as amended on December 19, 2025.
By Helus Pharma · Via GlobeNewswire · April 20, 2026
Ardelyx Appoints Biopharmaceutical Veteran, Felecia W. Ettenberg, as Chief Legal Officer
WALTHAM, Mass., April 20, 2026 (GLOBE NEWSWIRE) -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the development and commercialization of innovative medicines that meet significant unmet medical needs, today announced the appointment of Felecia W. Ettenberg, a seasoned leader with more than 25 years of legal experience in the biopharmaceutical industry, as Chief Legal Officer (CLO). She will oversee Ardelyx’s legal, compliance, regulatory, and government affairs operations. Ms. Ettenberg succeeds Elizabeth Grammer, who has chosen to retire after an extraordinary 16-year career at the company.
By Ardelyx, Inc. · Via GlobeNewswire · April 20, 2026
Tenvie Therapeutics Announces Dosing of First Subject in Phase 1 Clinical Trial of TNV108, an Allosteric SARM1 inhibitor
Second candidate from Tenvie’s product engine to enter clinical development
By Tenvie Therapeutics, Inc. · Via GlobeNewswire · April 20, 2026
LENZ Therapeutics Announces Submission of Marketing Authorization Application to the Medicines and Healthcare products Regulatory Agency for VIZZ® for the Treatment of Presbyopia in the United Kingdom
MHRA submission follows EMA validation of the VIZZ MAA in March 2026
By LENZ Therapeutics, Inc. · Via GlobeNewswire · April 20, 2026
Mountain Warehouse Launches Composable Ecommerce Store with BigCommerce to Accelerate Innovation and Global Growth
Outdoor retailer replaces legacy system with modern, headless architecture to improve scalability, flexibility and customer experience
By Commerce.com, Inc. · Via GlobeNewswire · April 20, 2026
AskBio's Viralgen to Supply Commercial-Scale Drug Product for REGENERATE-PD Investigational Gene Therapy Phase II Trial for Parkinson’s Disease
Berlin, Germany, and Durham, N.C., USA, April 20, 2026 (GLOBE NEWSWIRE) -- Not intended for UK Media
By AskBio Inc. (AskBio) · Via GlobeNewswire · April 20, 2026
Boehringer Ingelheim expands investment in computational innovation with new AI Accelerator in UK’s Knowledge Quarter
Ingelheim, Germany, and London, UK – Boehringer Ingelheim today announced the expansion of its global Computational Innovation footprint with the launch of a new center for AI and machine learning in King’s Cross, London, UK, part of the Knowledge Quarter ecosystem. As the company continues to innovate and expand its AI capabilities in pharmaceutical R&D, this significant investment recognizes the UK’s commitment to AI and the life sciences sector.
By Boehringer Ingelheim Limited · Via GlobeNewswire · April 20, 2026
Kyverna Presents Longer-Term Phase 2 Data for Miv-cel in Generalized Myasthenia Gravis at AAN, Demonstrating Deep, Durable Responses through 52 Weeks
100% of patients achieved rapid, sustained improvements across MG-ADL and QMG at 24 weeks, further increasing confidence in Phase 3 trial 
By Kyverna Therapeutics, Inc. · Via GlobeNewswire · April 20, 2026
Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
FLORHAM PARK, N.J., April 20, 2026 (GLOBE NEWSWIRE) -- Phathom Pharmaceuticals, Inc. (Nasdaq: PHAT), a biopharmaceutical company focused on commercializing and developing novel treatments for gastrointestinal (GI) diseases, today announced that it will host a live webcast at 8:00 am EDT on Thursday, April 30, 2026, to report its first quarter 2026 financial results and provide a business update.
By Phathom Pharmaceuticals · Via GlobeNewswire · April 20, 2026
Dynex Capital, Inc. Announces First Quarter 2026 Results
Dynex Capital, Inc. (the "Company") (NYSE: DX), a REIT with a long track record of generating dividends from high-quality mortgage assets, reported its first quarter financial results today. Management will host a call today at 10:00 a.m. Eastern Time to discuss the results and business outlook. Details to access the call can be found below under "Earnings Conference Call."
By Dynex Capital, Inc. · Via Business Wire · April 20, 2026
TTP Group Announces the Sale of LEX Diagnostics
TTP today announced the acquisition by QuidelOrtho Corporation (Nasdaq: QDEL), a global leader in in vitro diagnostics, of LEX Diagnostics Limited, a UK-based molecular diagnostics company and a spin-out of TTP Group.
By TTP Group · Via Business Wire · April 20, 2026
Simulations Plus Expands Global Access to Model-Informed Drug Development Training Through Its 2026 Spring School
Simulations Plus, Inc. (Nasdaq: SLP) (“Simulations Plus” or the “Company”), a global leader in model-informed and AI-accelerated drug development that advances biopharma innovation, today announced the successful completion of its 2026 Spring School, a global training initiative designed to expand access to model-informed drug development (MIDD) and strengthen the scientific foundation of the industry’s future workforce.
By Simulations Plus, Inc. · Via Business Wire · April 20, 2026
OnlineAssistant.ai Opens Elk Rapids AI agency Office for Northern Michigan Retailers and Businesses
OnlineAssistant.ai now has a walk-in office at 204 River Street, Suite H, Elk Rapids, MI, providing in-person AI consulting, local SEO and digital visibility support.
Via PRUnderground · April 20, 2026
RedCloud to Enter Live Deployment Phase as Combined Turkey and Saudi Joint Ventures Represent Up to $80 Million Revenue
Joint ventures underpin up to $80 million in contracted value across key global trade corridors, marking a transition to early-stage deployment with one of Turkey’s leading distribution networks
By RedCloud Holdings plc · Via GlobeNewswire · April 20, 2026
GMG's Graphene Engine Oil Additive G(R) LUBRICANT: Patent Granted in USA; Allowed in China
Brisbane, Queensland, Australia--(Newsfile Corp. - April 20, 2026) - Graphene Manufacturing Group Ltd (TSXV: GMG) (OTCQX: GMGMF) ("GMG" or the...
Via Newsfile · April 20, 2026
NewcelX Updates Corporate Presentation to Highlight Type 1 Diabetes Flagship Program Following Strategic Collaboration with Eledon Pharmaceuticals Ahead of Swiss Biotech Conference
ZURICH, Switzerland, April 20, 2026 (GLOBE NEWSWIRE) -- NewcelX Ltd. (Nasdaq: NCEL),– NewcelX Ltd. (Nasdaq: NCEL), a clinical-stage regenerative medicine company developing stem-cell-derived therapies, today announced the release of an updated corporate presentation that includes the company’s strategic collaboration with Eledon Pharmaceuticals (Nasdaq: ELDN) and highlights the advancement of its flagship Type 1 Diabetes program, NCEL-101, as a central pillar of the company’s development strategy.
By NewcelX Ltd. · Via GlobeNewswire · April 20, 2026